RecruitingPhase 3ACTRN12605000280606

Isocapnic intermittent hypoxia and endothelial dysfunction

The effects of nitric oxide synthase inhibition on arterial stiffness during short term hypoxic exposure in healthy men


Sponsor

NHMRC

Enrollment

10 participants

Start Date

May 15, 2003

Study Type

Interventional

Conditions


Eligibility

Sex: Males

Inclusion Criteria1

  • Healthy men

Exclusion Criteria1

  • History of obstructive sleep apnoea or cardiovascular or respiratory disease, Smoker, Treatment with cardiovascular or respiratory medication.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Subjects will be infused with L-N monomethyl arginine (LNMMA) and saline (placebo) in a single blinded randomized design on two separate days to assess the effect of nitric oxide synthase inhibition o

Subjects will be infused with L-N monomethyl arginine (LNMMA) and saline (placebo) in a single blinded randomized design on two separate days to assess the effect of nitric oxide synthase inhibition on arterial stiffness. Initially there will be a 10 minute baseline period. Then the LNMMA or saline will be infused over 5 minutes, after which there will be another 5 minute baseline period. Following this there will be the 20 minute period of hypoxia and then a 10 minute recovery period. During this the subjects will breathe through a mouthpiece connected to special equipment which delivers different gas mixtures and enables the delivery of the hypoxic exposure. Heart rate blood pressure, arterial stiffness ( via pulse wave analysis), and peripheral vasoconstriction (via peripheral arterial tonometry PAT) will be measured.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12605000280606